CATHERINE WALKER: Open Payments
NPI 1730702499 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,734 in 143 payments from 22 companies in 2025. Trend: 2023 $2,070 · 2024 $2,593 · 2025 $2,734
Food & beverage: $2,644Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $363 |
| Regeneron Healthcare Solutions, Inc. | 7 | $263 |
| GlaxoSmithKline, LLC. | 19 | $263 |
| Verona Pharma, Inc. | 28 | $244 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $171 |
| Viatris Specialty LLC | 11 | $166 |
| Actelion Pharmaceuticals US, Inc. | 5 | $151 |
| Amgen Inc. | 7 | $138 |
| Genentech USA, Inc. | 4 | $110 |
Products named: DUPIXENT, Ohtuvayre, FASENRA, TEZSPIRE, YUPELRI, GLASSIA, NUCALA, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
